Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.

Yoshida O, Kimura S, Jackson EK, Robson SC, Geller DA, Murase N, Thomson AW.

Hepatology. 2013 Dec;58(6):2163-75. doi: 10.1002/hep.26593. Epub 2013 Oct 15.

PMID:
23813862
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.

Guckelberger O, Sun XF, Sévigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, Robson SC.

Thromb Haemost. 2004 Mar;91(3):576-86.

PMID:
14983235
[PubMed - indexed for MEDLINE]
3.

CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.

Yoshida O, Dou L, Kimura S, Yokota S, Isse K, Robson SC, Geller DA, Thomson AW.

Transpl Immunol. 2015 Feb 7. pii: S0966-3274(15)00004-0. doi: 10.1016/j.trim.2015.01.003. [Epub ahead of print]

PMID:
25661084
[PubMed - as supplied by publisher]
4.

Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.

Pommey S, Lu B, McRae J, Stagg J, Hill P, Salvaris E, Robson SC, d'Apice AJ, Cowan PJ, Dwyer KM.

Hepatology. 2013 Apr;57(4):1597-606. doi: 10.1002/hep.25985. Epub 2013 Mar 14.

PMID:
22829222
[PubMed - indexed for MEDLINE]
5.

Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury.

Crikis S, Lu B, Murray-Segal LM, Selan C, Robson SC, D'Apice AJ, Nandurkar HH, Cowan PJ, Dwyer KM.

Am J Transplant. 2010 Dec;10(12):2586-95. doi: 10.1111/j.1600-6143.2010.03257.x. Epub 2010 Sep 14.

PMID:
20840479
[PubMed - indexed for MEDLINE]
Free Article
6.

Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.

Beldi G, Banz Y, Kroemer A, Sun X, Wu Y, Graubardt N, Rellstab A, Nowak M, Enjyoji K, Li X, Junger WG, Candinas D, Robson SC.

Hepatology. 2010 May;51(5):1702-11. doi: 10.1002/hep.23510.

PMID:
20146261
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK.

J Immunol. 2010 Apr 1;184(7):4017-24. doi: 10.4049/jimmunol.0901851. Epub 2010 Mar 5.

PMID:
20207994
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation.

Ueki S, Castellaneta A, Yoshida O, Ozaki K, Zhang M, Kimura S, Isse K, Ross M, Shao L, Stolz DB, Thomson AW, Demetris AJ, Geller DA, Murase N.

Hepatology. 2011 Jul;54(1):216-28. doi: 10.1002/hep.24360.

PMID:
21503939
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia/reperfusion injury.

Zhang M, Ueki S, Kimura S, Yoshida O, Castellaneta A, Ozaki KS, Demetris AJ, Ross M, Vodovotz Y, Thomson AW, B Stolz D, Geller DA, Murase N.

Hepatology. 2013 Apr;57(4):1585-96. doi: 10.1002/hep.26129.

PMID:
23184590
[PubMed - indexed for MEDLINE]
10.

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K.

Blood. 2007 Aug 15;110(4):1225-32. Epub 2007 Apr 20.

PMID:
17449799
[PubMed - indexed for MEDLINE]
Free Article
11.

Apyrase treatment prevents ischemia-reperfusion injury in rat lung isografts.

Sugimoto S, Lin X, Lai J, Okazaki M, Das NA, Li W, Krupnick AS, Chen R, Jeong SS, Patterson GA, Kreisel D, Gelman AE.

J Thorac Cardiovasc Surg. 2009 Sep;138(3):752-9. doi: 10.1016/j.jtcvs.2009.04.049. Epub 2009 Jul 10.

PMID:
19698866
[PubMed - indexed for MEDLINE]
12.

Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.

Zhang H, Stolz DB, Chalasani G, Thomson AW.

Clin Exp Immunol. 2013 Sep;173(3):473-9. doi: 10.1111/cei.12126.

PMID:
23617623
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Deletion of cd39/entpd1 results in hepatic insulin resistance.

Enjyoji K, Kotani K, Thukral C, Blumel B, Sun X, Wu Y, Imai M, Friedman D, Csizmadia E, Bleibel W, Kahn BB, Robson SC.

Diabetes. 2008 Sep;57(9):2311-20. doi: 10.2337/db07-1265. Epub 2008 Jun 20.

PMID:
18567823
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Attenuated allergic airway inflammation in Cd39 null mice.

Idzko M, K Ayata C, Müller T, Dürk T, Grimm M, Baudiß K, Vieira RP, Cicko S, Boehlke C, Zech A, Sorichter S, Pelletier J, Sévigny J, Robson SC.

Allergy. 2013 Apr;68(4):472-80. doi: 10.1111/all.12119. Epub 2013 Mar 1.

PMID:
23452076
[PubMed - indexed for MEDLINE]
15.

Transgenic swine: expression of human CD39 protects against myocardial injury.

Wheeler DG, Joseph ME, Mahamud SD, Aurand WL, Mohler PJ, Pompili VJ, Dwyer KM, Nottle MB, Harrison SJ, d'Apice AJ, Robson SC, Cowan PJ, Gumina RJ.

J Mol Cell Cardiol. 2012 May;52(5):958-61. doi: 10.1016/j.yjmcc.2012.01.002. Epub 2012 Jan 12.

PMID:
22269791
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.

Köhler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, Hart ML, Robson SC, Müller CE, Eltzschig HK.

Circulation. 2007 Oct 16;116(16):1784-94. Epub 2007 Oct 1. Erratum in: Circulation. 2007 Oct 30;116(18):e514.

PMID:
17909107
[PubMed - indexed for MEDLINE]
Free Article
17.

Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K, Haschemi A, Yegutkin GG, Candinas D, Exley M, Robson SC.

Hepatology. 2008 Sep;48(3):841-52. doi: 10.1002/hep.22401. Erratum in: Hepatology. 2009 Jul;50(1):331.

PMID:
18752325
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X, Robson SC.

Front Biosci. 2008 Jan 1;13:2588-603. Review.

PMID:
17981736
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.

Imai M, Takigami K, Guckelberger O, Enjyoji K, Smith RN, Lin Y, Csizmadia E, Sévigny J, Rosenberg RD, Bach FH, Robson SC.

Mol Med. 1999 Nov;5(11):743-52. Erratum in: Mol Med 2000 Dec;6(12):1063.

PMID:
10656876
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.

Feng L, Sun X, Csizmadia E, Han L, Bian S, Murakami T, Wang X, Robson SC, Wu Y.

Neoplasia. 2011 Mar;13(3):206-16.

PMID:
21390184
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk